Search for:
Limit by:
  Browse by Topic or Issue
Home Search Subscribe PDA Services Contact Help

(These articles have been accepted for this issue. Change is possible before publication.)


Receive this page by email each issue: [Sign up for eTOCs]

Future Table of Contents: Mar 1, 2004; 22 (5)

       Original Reports
       Lung Cancer
       Pediatric Oncology
       Neurooncology
       Breast Cancer
       Gynecologic Cancer
       Sarcomas
       Gastrointestinal Cancer
       Genitourinary Cancer
       Supportive Care and Quality of Life
       Phase I and Clinical Pharmacology
       Review Article
       The Art of Oncology: When the Tumor is Not the Target

Original Reports

Lung Cancer


Gefitinib (ZD1839) in Combination With Gemcitabine and Cisplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial (INTACT 1)
Giuseppe Giaccone, Roy S. Herbst, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Vincent Miller, Ronald B. Natale, Joan H. Schiller, Joachim von Pawel, Anna Pluzanska, Ulrich Gatzemeier, John Grous, Judith S. Ochs, Steven D. Averbuch, Michael K. Wolf, Pamela Rennie, Abderrahim Fandi, and David H. Johnson

Gefitinib (ZD1839) in Combination With Paclitaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer: A Phase III Trial (INTACT 2)
Roy S. Herbst, Giuseppe Giaccone, Joan H. Schiller, Ronald B. Natale, Vincent Miller, Christian Manegold, Giorgio Scagliotti, Rafael Rosell, Ira Oliff, James A. Reeves, Michael K. Wolf, Annetta D. Krebs, Steven D. Averbuch, Judith S. Ochs, John Grous, Abderrahim Fandi, and David H. Johnson

Hu and VGCC Antibodies Related to the Prognosis of Small-Cell Lung Cancer
S.E. Monstad, L. Drivsholm, A. Storstein, J.H. Aarseth, M. Haugen, B. Lang, A. Vincent, and C.A. Vedeler

Hypofractionated Palliative Radiotherapy in Advanced Non--Small-Cell Lung Carcinoma Is Comparable With Standard Fractionation for Symptom Control and Survival: A Phase III Trial
Stein Sundstrom, Roy Bremnes, Ulf Aasebo, Steinar Aamdal, Reidulv Hatlevoll, Paal Brunsvig, Dag Clement Johannessen, Olbjorn Klepp, Peter M. Fayers, and Stein Kaasa

Prognostic Model of Adenocarcinoma of the Lung by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time RT-PCR
Hideki Endoh, Shuta Tomida, Yasushi Yatabe, Hiroyuki Konishi, Hirotaka Osada, Kohei Tagima, Hiroyuki Kuwano, Takashi Takahashi, and Tetsuya Mitsudomi

Pediatric Oncology

Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to Anthracyclines
Jeffrey H. Silber, Avital Cnaan, Bernard J. Clark, Stephen M Paridon, Alvin J. Chin, Jack Rychik, Alexa N. Hogarty, Mitchell I. Cohen, Gerald Barber, Monika Rutkowski, Thomas R. Kimball, Cynthia DeLaat, Laurel J. Steinherz, and Huaqing Zhao

Phase I and Pharmacokinetic Study of Topotecan Administered to Pediatric Patients With Refractory Solid Tumors
Najat C. Daw, Victor M. Santana, Lisa C. Iacono, Wayne L. Furman, Dana R. Hawkins, Peter J. Houghton, J. Carl Panetta, Amar J. Gajjar, and Clinton F. Stewart

Clinical and Outcome Characteristics of Children With Adrenocortical Tumors: An Analysis From the International Pediatric Adrenocortical Tumor Registry
E. Michalkiewicz, R. Sandrini, B. Figueiredo, E.C.M. Miranda, E. Caran, A.G. Oliveira-Filho, R. Marques, M.A.D. Pianovski, L. Lacerda, L.M. Cristofani, J. Jenkins, C. Rodriguez-Galindo, and R.C. Ribeiro

Neurooncology

Primary Chemotherapy for Intracranial Non-Germinomatous Germ Cell Tumors: Results of the Second International CNS Germ Cell Study Group Protocol
Stewart J. Kellie, Hayden Boyce, Ira J. Dunkel, Blanca Diez, Marc Rosenblum, Lynette Brualdi, and Jonathan L. Finlay

Breast Cancer

HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Elena B. Elkin, Milton C. Weinstein, Eric P. Winer, Karen M. Kuntz, Stuart J. Schnitt, and Jane C. Weeks

Activity and Safety of the Orally Active Precursor of EM-652 (Acolbifene) in Tamoxifen-Resistant Breast Cancer
Fernand Labrie, Pierre Champagne, Claude Labrie, Jean Roy, Jacques Laverdiere, Louise Provencher, Martin Potvin, Yvan Drolet, Michael Pollak, Lawrence Panasci, Bernard L'esperance, Jean Dufresne, Jean Latreille, Jean Robert, Benoit Samson, Jacques Jolivet, Louise Yelle, Lionel Cusan, Pierre Diamond, and Bernard Candas

Gynecologic Cancer

Pelvic Irradiation With Concurrent Chemotherapy Compared With Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial RTOG 90-01
Patricia J. Eifel, Kathryn Winter, Mitchell Morris, Charles Levenback, Perry W. Grigsby, Jay Cooper, Marvin Rotman, David Gershenson, and David G. Mutch

Predictors of Sexual Functioning in Ovarian Cancer Patients
Cindy L. Carmack Taylor, Karen Basen-Engquist, Eileen H. Shinn, and Diane C. Bodurka

Sarcomas

Phase II Study of Ecteinascidin-743 in Previously Treated Soft-Tissue Sarcoma
A. Yovine, M. Riofrio, J.Y. Blay, E. Brian, J. Alexandre, C. Kahatt, A. Taamma, J. Jimeno, C. Martin, Y. Salhi, E. Cvitkovic, and J.L. Misset

Gastrointestinal Cancer

Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment
Hinrich A. Wieder, Bjorn L.D.M. Brucher, Frank Zimmermann, Karen Becker, Andreas Sendler, Florian Lordick, Ambros Beer, Markus Schwaiger, Ulrich Fink, Jorg Rudiger Siewert, Hubert J. Stein, and Wolfgang A. Weber

Genitourinary Cancer

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel mTOR Kinase Inhibitor, in Patients With Advanced Refractory Renal-Cell Carcinoma
Michael B. Atkins, Manuel Hidalgo, Walter M. Stadler, Theodore F. Logan, Janice P. Dutcher, Gary R. Hudes, Young Park, Song-Heng Liou, Bonnie Marshall, Joseph P. Boni, Gary Dukart, and Matthew L. Sherman

Supportive Care and Quality of Life

Prevalence and Predictors of Psychological Distress Among Women With Ovarian Cancer
Tina R. Norton, Sharon L. Manne, Stephen Rubin, John Carlson, Enrique Hernandez, Mitchell I. Edelson, Norman Rosenblum, David Warshal, and Cynthia Bergman

Lamivudine for the Prevention of Hepatitis B Virus Reactivation in HBsAg Seropositive Cancer Patients Undergoing Cytotoxic Chemotherapy
Winnie Yeo, Paul K.S. Chan, Wing M. Ho, Benny Zee, Kwok C. Lam, Kenny I.K. Lei, Anthony T.C. Chan, Tony S.K. Mok, Jam J. Lee, Thomas W.T. Leung, Sheng Zhong, and Philip J. Johnson

Phase I and Clinical Pharmacology

Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial of Chronic Myeloid Leukemia Patients
Bin Peng, Michael Hayes, Debra Resta, Amy Racine-Poon, Brian J. Druker, Moshe Talpaz, Charles L. Sawyers, Marianne Rosamilia, John Ford, Peter Lloyd, and Renaud Capdeville

Review Article

Short-Term Impact of Cancer Prevention and Screening Activities on Quality of Life
Jennifer Cullen, Marc D. Schwartz, William F. Lawrence, Joe V. Selby, and Jeanne S. Mandelblatt

The Art of Oncology: When the Tumor is Not the Target

On the Death of a Spouse: Reflections of a Medical Oncologist
Peter A. Beatty

Submission Information Editorial Roster Advertising Information E-mail Alerts Feedback

Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
HighWire Press™ assists in the publication of JCO Online